Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS(40) Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response

Cell-free antitumor vaccines represent a promising approach to immunotherapy of cancer. Here, we compare the antitumor potential of cell-free vaccines based on microvesicles derived from dendritic cells (DCs) with DC- and cationic-liposome-based vaccines using a murine model of drug-resistant lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Markov, Oleg V., Sen’kova, Aleksandra V., Mohamed, Islam S., Shmendel, Elena V., Maslov, Mikhail A., Oshchepkova, Anastasiya L., Brenner, Evgeniy V., Mironova, Nadezhda L., Zenkova, Marina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696603/
https://www.ncbi.nlm.nih.gov/pubmed/36432733
http://dx.doi.org/10.3390/pharmaceutics14112542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696603/
https://www.ncbi.nlm.nih.gov/pubmed/36432733
http://dx.doi.org/10.3390/pharmaceutics14112542

Ejemplares similares